Cencora, Inc.
Market cap $59.0B
$308.76
COR
$308.76
-0.01% today
Buy with €1M virtual cash · No real money
Cencora, Inc. (COR) is a publicly traded company listed on the XNYS. As of September 19, 2026, Invest's signal rates COR a Buy, with the stock up 7% over the past year. You can practice trading COR risk-free with €1,000,000 in virtual cash.
Key stats
As of September 19, 2026
Market Cap
$59.0B
Volume
3.3M
52-wk High
$377.54
52-wk Low
$244.82
Day High
$311.81
Day Low
$304.45
P/E (TTM)
22.92
Revenue (TTM)
$332.8B
EPS (TTM)
$13.47
Performance
1M
-2.6%
6M
-6.9%
1Y
+6.8%
Invest signal · COR
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
COR overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +8.2%Revenue
$85BEPS (diluted)
$3.94 per shareLatest COR news
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 17h ago
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · 4d ago
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · Sep 11
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Zacks Investment Research · Sep 4
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · Sep 4
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry.
Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Employees
51,000
30-Day Win Rate · COR
12 days
11 days
Last 23 sessions
How to practice trading COR
- 1
Use the COR buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top COR traders on Invest
Full leaderboardFrequently asked questions
Is COR a good stock to buy right now?
As of September 19, 2026, Invest's signal rates COR a Buy, based on its price trend, valuation, and fundamentals (P/E around 22.9), with the stock up 7% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading COR risk-free first.
What is Cencora, Inc.'s (COR) market cap?
Cencora, Inc. has a market capitalization of approximately $59.0B, on trailing-twelve-month revenue of about $332.8B.
How has COR stock performed?
COR is up 7% over the past year and down 7% over six months. Its 52-week range runs roughly from $244.82 to $377.54. Past performance doesn't predict future results.
How can I practice trading COR for free?
On Invest you get €1,000,000 in virtual cash and can buy COR at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare COR with peers